Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
2
×
national top stories
akcea therapeutics
alnylam pharmaceuticals
boston
cancer
crispr
crispr therapeutics
crispr-cas9
drugs
editas
editas medicine
european medicines agency
fda
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
intellia therapeutics
national
new york blog main
new york top stories
onpattro
p53
patisiran
pfizer
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
What
cells
2
×
gene
2
×
medicine
alnylam
approves
cancer
cas
crispr
defect
drive
drug
edited
editing
ema
employ
europe
fda
fears
flag
follows
genetic
guardian
harmful
hits
human
interference
known
lab
make
malfunction
method
mute
nature
new
nicknamed
occurs
papers
potential
protein
published
Language
Current search:
" national blog main "
×
gene
×
cells
×
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
